OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel non-covalent conjugate based on graphene oxide and alkylating agent from 1,3,5-triazine class
Vladimir V. Sharoyko, Olga V. Mikolaichuk, Olga S. Shemchuk, et al.
Journal of Molecular Liquids (2023) Vol. 372, pp. 121203-121203
Closed Access | Times Cited: 10

Showing 10 citing articles:

Modification of fullerene with amino acids as a method for obtaining biocompatible materials with a protective effect
Vladimir V. Sharoyko, Olga S. Shemchuk, Anatolii A. Meshcheriakov, et al.
Fullerenes Nanotubes and Carbon Nanostructures (2024) Vol. 32, Iss. 7, pp. 631-639
Closed Access | Times Cited: 3

Development of Graphene-Based Materials with the Targeted Action for Cancer Theranostics
Konstantin N. Semenov, Olga S. Shemchuk, Sergei V. Ageev, et al.
Biochemistry (Moscow) (2024) Vol. 89, Iss. 8, pp. 1362-1391
Open Access | Times Cited: 2

Synthesis, characterization and biocompatibility of glycine modified graphene oxide
Vladimir V. Sharoyko, Olga S. Shemchuk, Anatolii A. Meshcheriakov, et al.
Fullerenes Nanotubes and Carbon Nanostructures (2023) Vol. 32, Iss. 3, pp. 288-299
Closed Access | Times Cited: 5

Non-covalent conjugate based on graphene oxide and a cytotoxic agent containing 1,3,5-triazine derivative and (5-phenyl-2H-tetrazol-2-yl)acetoxy moiety: Synthesis, characterization, properties and cytotoxic activity
Olga V. Mikolaichuk, Olga S. Shemchuk, A. V. Protas, et al.
Mendeleev Communications (2023) Vol. 33, Iss. 6, pp. 790-792
Closed Access | Times Cited: 4

Atranorin is a novel potential candidate drug for treating myelodysplastic syndrome
Konstantin N. Semenov, I. А. Prokopiev, Natalya V. Petukhova, et al.
Research Square (Research Square) (2024)
Open Access

Adduct of fullerene C 60 with l -arginine: interaction with DNA, genotoxic and mutagenic properties
Olegi N. Kukaliia, Sergei V. Ageev, Andrey V. Petrov, et al.
Fullerenes Nanotubes and Carbon Nanostructures (2024) Vol. 32, Iss. 10, pp. 916-927
Closed Access

Atranorin is a novel potential candidate drug for treating myelodysplastic syndrome
Konstantin N. Semenov, I. А. Prokopiev, Petukhova Nv, et al.
Journal of Molecular Liquids (2024) Vol. 413, pp. 125743-125743
Open Access

Cytotoxicity and photothermal properties of graphene oxide conjugate with folic acid and a cytostatic agent of styryl thiazolopyrimidinium class
Konstantin N. Semenov, Olga S. Shemchuk, B. V. Paponov, et al.
Fullerenes Nanotubes and Carbon Nanostructures (2024), pp. 1-8
Closed Access

Covalent conjugate based on graphene oxide and alkylating agent belonging to 1,3,5-triazine class as promising agent for anticancer chemo- and phototherapy
Konstantin N. Semenov, Olga S. Shemchuk, Olga V. Mikolaichuk, et al.
Journal of Molecular Structure (2024), pp. 141046-141046
Closed Access

Biomedical use of nanoconjugates based on graphene oxide and fullerenes with cytostatic drugs.
A. V. Protas, E. A. Popova, Olga V. Mikolaichuk, et al.
Translational Medicine (2023) Vol. 10, Iss. 5, pp. 402-411
Open Access

Page 1

Scroll to top